Market Overview

Sonim Technologies Issues Warning For 2019 Sales

Share:

Sonim Technologies (NASDAQ: SONM) management has lowered its financial guidance for this fiscal year ending Dec. 31.

The company says net revenues are expected to be flat or slightly below 2018 net revenues of $135.7 million reported in fiscal 2018.

Sonim Technologies explainsthere are several factors which have collectively contributed to the company's revised financial outlook for fiscal 2019, primarily stemming from changes in U.S. wireless carrier forecasts for the launch of Sonim's new products as well as launch delays due to software issues related to these new introductions.

The company reports GAAP net loss, defined as net revenues less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses, is expected to be up to $15 million. The company has adjusted EBITDA, a non-GAAP metric to be a loss of up to $5 million.

Sonim Technologies shares closed Monday at $7.06. The stock has a 52-week high of $18.26 and a 52-week low of $6.62.

Related Links:

Alcoa To Consolidate Sales, Procurement And Commercial Operations, Cuts Staff

Genesco Reports Mixed Q2 Earnings, Raises Guidance

Posted-In: News Guidance

 

Related Articles (SONM)

View Comments and Join the Discussion!
Need corporate guidance data?
Click here to see licensing options.
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Morocco: Europe's Biggest Cannabis Supplier

Michigan Pure Med Calls For Stronger Safety Standards Following MRA's Largest Recall To Date